Skip to main content

Peer Review reports

From: A beneficial levels of 25-hydroxyvitamin D for a decrease in thyrotropin receptor antibody (TRAB) in patients with Graves’ disease: a real-world study

Original Submission
26 Nov 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
29 Dec 2023 Author responded Author comments - Sunjie Yan
Resubmission - Version 4
29 Dec 2023 Submitted Manuscript version 4
19 Jan 2024 Author responded Author comments - Sunjie Yan
Resubmission - Version 5
19 Jan 2024 Submitted Manuscript version 5
19 Sep 2024 Reviewed Reviewer Report - Vinh Q. Mai
24 Sep 2024 Reviewed Reviewer Report
6 Oct 2024 Author responded Author comments - Sunjie Yan
Resubmission - Version 6
6 Oct 2024 Submitted Manuscript version 6
7 Oct 2024 Author responded Author comments - Sunjie Yan
Resubmission - Version 7
7 Oct 2024 Submitted Manuscript version 7
8 Oct 2024 Author responded Author comments - Sunjie Yan
Resubmission - Version 8
8 Oct 2024 Submitted Manuscript version 8
17 Oct 2024 Reviewed Reviewer Report - Vinh Q. Mai
Resubmission - Version 9
Submitted Manuscript version 9
Publishing
20 Dec 2024 Editorially accepted
21 Jan 2025 Article published 10.1186/s12902-024-01823-x

You can find further information about peer review here.

Back to article page